Breaking News on Supplements & Nutrition - North AmericaEU edition

Vitamins & premixes

News headlines

Vitamin C and E supplements hinder endurance training: Study

Athletes supplementing with vitamin C and E could be harming their endurance ability, a study by Norwegian researchers suggests.

Study linking vitamin E with cancer 'irrelevant' for human supplementation, CRN says

Once again, negative results from a tightly focused study with a nutraceutical ingredient have been generalized in the mainstream media as a blanket condemnation.  In this case, it was the news that megadoses of vitamin E fed to cancer-prone mice caused their tumors to grow faster.  Despite the hubbub, it’s news that is, as far as human supplementation is concerned, “irrelevant,” said Duffy MacKay of the Council for Responsible Nutrition.

Sports nutrition popularity boosts price of some pre workout supplement ingredients

Strong demand from consumers for sports nutrition products is working its way backward into teh supply of the popular ingredients for these products, sending their prices up, according to a survey from ingredients supplier GWI.

$130 million in financing to underpin Twinlab management buyout

Capstone Financial Group will act as advisor and help raise $130 million in financing to underpin a planned management buyout of Twinlab Corp. and attendant formation of a new entity aimed at future acquisitions.

Vitamin D may be linked to multiple sclerosis activity and progression: Study

High levels of vitamin D may be associated with reduced disease activity and a lower risk of progression for people with multiple sclerosis (MS), according to new research.

Nutraceutical blend may ease dry eye symptoms: Study

A combination of omega-3s and antioxidants may significantly reduce dry eye symptoms, including ‘scratchy’ eyes, eye redness, and blurry vision, according to a new study.

Vitamin D benefits may be due to nitric oxide mechanisms: Mouse data

Vitamin D could play a vital role in the regulation of cardiovascular function - and the risk of several disease states - by controlling arterial stiffness and levels of nitric oxide, according to new research in mice.

Vitamin E supplements may reduce bone fracture rate in the elderly: Study

Use of vitamin E alpha-tocopherol supplements may reduce the rate of bone fractures in older people, says a new study that supports the potential bone health benefits of the vitamin.

Simpler blood test for vitamin D could enhance preventive care, developer says

In another way point in the personalized healthcare movement, Purity Labs of Portland, OR has announced the development of a vitamin D blood test that involves obtaining only small spots of blood applied to cards. The new test lowers costs, simplifies shipping and makes the test easier for practitioners and might mean consumers could do it themselves, the developer says.

Guest article

Supplements shakedown part 2: Health claim medicine tastes better than expected

Last week, Peter Zambetti, director of global business development at Capsugel and chairman of the International Alliance of Dietary Supplement Associations (IADSA), discussed the impact of GMPs on the global health & nutrition (H&N) sector. In part 2 of this Q&A, he examines the impact of health claims laws that have gone through great change in many parts of the world in recent years.

Guest article

Supplements shakedown: Globalisation and a brave new world of regulations

The global health and nutrition (H&N) sector continues to expand, but regulations are tighter than ever and players need to understand this if they are to succeed, says the chief of the biggest global supplements organisation.

Want a stronger baby? Get a higher vitamin D intake, suggests study

Children are likely to have stronger muscles if their mothers have a higher level of vitamin D in their body during pregnancy, according to new research.

Focus on bio-availability and not just label claims to make people nutrient replete: Ashoka fellow

The food and nutrition industries should be focusing on bioavailablity and bioefficacy of nutrients, and not just on big numbers on product labels, says a leading social entrepreneur who has spent over a decade boosting the nutritional status of the severely malnourished across Africa.

InterHealth acquired by private equity firm

Specialty ingredient supplier InterHealth Nutraceuticals has been acquired by private equity firm Kainos Capital, the company announced Tuesday.  Details of the deal were not disclosed.

ChromaDex signs $62 million deal for Niagen, Purenergy ingredients

ChromaDex has announced the largest deal in its history, a $62 million agreement with nework marketing company 5LINX that covers its Niagen and Purenergy ingredients.

Algal extract may support healthy cholesterol balance: Hamster data

Supplementation with a proprietary algal extract may counter the effects of high-fat diets by supporting healthy cholesterol and lipid status, according to new research in hamsters.

FDA warns consumers about supplements making brain trauma protection claims

The Food and Drug Administration has put industry on notice that it won’t tolerate the rising tide of dietary supplement ingredients being marketed for their role in ameliorating the effects of traumatic brain injury.

Most vitamin studies are flawed by poor methodology, say Linus Pauling researchers

Many large clinical trials of vitamin supplements, including those concluding vitamins are of no value or may even be harmful, have a flawed methodologies that means they are 'useless' in determining the real value of such micronutrients, according to a new analysis.

News in brief

NBTY says it donated $7 million to charity in 2013

Vitamin manufacturing giant NBTY donated more than $7 million in cash and products to charitable causes in 2013, according to the company.

‘Significant’: Vitamin E may slow functional decline in moderate Alzheimer patients

Daily supplements of vitamin E (alpha tocopherol) may slow functional decline in people with mild to moderate Alzheimer’s disease, say results of a double-blind, placebo-controlled, parallel-group, randomized clinical trial.

Key Industry Events


Access all events listing

Our events, Events from partners...

Related News

Product Innovation